Trial intelligence / Profile preview

Gabapentin versus capsaicin for heart rate variability in diabetic painful peripheral neuropathy

IRCT201308179014N18Phase 2Completed

Sponsor
Hamadan University of Medical Sciences
Start
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of gabapentin and capsaicin in diabetic polyneuropathy (DPN) (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Change in heart rate variability. Started Sep 2013; status: completed.

02

Drugs

gabapentincapsaicin
03

Conditions

diabetic polyneuropathy (DPN)

Beyond the preview

Go deeper on IRCT201308179014N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201308179014N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call